City of Hope, also known as CTCA, is a non-profit organization headquartered in the US, operating as a tier 1 media tech buyer. Founded in 1988 with approximately 2,660 employees, the organization specializes in hospitals and health care. It functions as a private, non-profit clinical cancer research center and hospital located in California, United States, having previously been known as Cancer Treatment Centers of America.
On April 4, 2026, Dr. Charles Brenner, a metabolism researcher who operates a lab at a City of Hope cancer center in California, discussed his simple lifestyle habits aimed at reducing cancer risk. Brenner's research focuses on the complex relationship between metabolism and disease, particularly NAD, which he described as the "central catalyst of all living things," likening its function to copper wiring in an electric car. Previously, on April 2, 2026, Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, announced reaching 160 publications. His work builds upon immunotherapy novel clinical trials and liquid biopsies for patients with colorectal cancer and other malignancies, including a recent article with Maria F. Teixeira on the utility of circulating tumor DNA-based liquid biopsies in cancer patients receiving immunotherapy.
Similar Companies
Subscribe for full access to City of Hope (CTCA)'s profile
City of Hope (CTCA) offers products in the media and telecoms services industry. City of Hope (CTCA)'s product portfolio comprises of media and TV services.
Subscribe for full access to City of Hope (CTCA)'s products in full detail
Subscribe for full access to City of Hope (CTCA)'s revenue in full detail
Subscribe for full access to City of Hope (CTCA)'s products in full detail 
